OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A global federated real-world data and analytics platform for research
Matvey B. Palchuk, Jack London, David Pérez-Rey, et al.
JAMIA Open (2023) Vol. 6, Iss. 2
Open Access | Times Cited: 169

Showing 1-25 of 169 citing articles:

Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes
Lindsey Wang, Rong Xu, David C. Kaelber, et al.
JAMA Network Open (2024) Vol. 7, Iss. 7, pp. e2421305-e2421305
Open Access | Times Cited: 47

Clinical Outcomes of Tirzepatide or GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes
Min‐Hsiang Chuang, Jui‐Yi Chen, Hsien‐Yi Wang, et al.
JAMA Network Open (2024) Vol. 7, Iss. 8, pp. e2427258-e2427258
Open Access | Times Cited: 17

Comparative Outcomes of Empagliflozin to Dapagliflozin in Patients With Heart Failure
Katherine L. Modzelewski, Alexandra Pipilas, Nicholas A. Bosch
JAMA Network Open (2024) Vol. 7, Iss. 5, pp. e249305-e249305
Open Access | Times Cited: 13

Cannabis Use and Head and Neck Cancer
Tyler J. Gallagher, Ryan S. Chung, Matthew E. Lin, et al.
JAMA Otolaryngology–Head & Neck Surgery (2024)
Closed Access | Times Cited: 9

Morbidity and mortality risks associated with valproate withdrawal in young men and women with epilepsy
Gashirai K Mbizvo, Tommaso Bucci, Gregory Y.H. Lip, et al.
Brain (2024) Vol. 147, Iss. 10, pp. 3426-3441
Closed Access | Times Cited: 8

Association of antiseizure medications and adverse cardiovascular events: A global health federated network analysis
Joséphine Mayer, Gashirai K Mbizvo, Tommaso Bucci, et al.
Epilepsia (2024) Vol. 65, Iss. 5, pp. 1264-1274
Open Access | Times Cited: 7

Increased cardiovascular risks and mortality in prurigo nodularis: a global cohort study
Henning Olbrich, Khalaf Kridin, Gema Hernández, et al.
EBioMedicine (2024) Vol. 103, pp. 105123-105123
Open Access | Times Cited: 7

The Effect of Human Growth Hormone Treatment on the Development of Slipped Capital Femoral Epiphysis: A Cohort Analysis With 6 Years of Follow-up
Mehul M. Mittal, David Momtaz, Rishi Gonuguntla, et al.
Journal of Pediatric Orthopaedics (2024) Vol. 44, Iss. 4, pp. e344-e350
Closed Access | Times Cited: 5

Risk of death, major adverse cardiac events and relapse in patients with bullous pemphigoid treated with systemic or topical corticosteroids
Khalaf Kridin, Katja Bieber, Artem Vorobyev, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 4, pp. 539-547
Closed Access | Times Cited: 5

Five-year Incidence of Progression to Osteoarthritis and Total Joint Arthroplasty in Patients Prescribed Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists
Monish S. Lavu, Joshua R. Porto, Christian J. Hecht, et al.
The Journal of Arthroplasty (2024)
Closed Access | Times Cited: 5

SARS-CoV-2 Infection and New-Onset Type 2 Diabetes Among Pediatric Patients, 2020 to 2022
Mark Steven Miller, Pauline Terebuh, David C. Kaelber, et al.
JAMA Network Open (2024) Vol. 7, Iss. 10, pp. e2439444-e2439444
Open Access | Times Cited: 5

The Role of Medical Comorbidities in Rotator Cuff Retear After Arthroscopic Repair: A TriNetX Database Review of 98,844 Patients
Yusuf Mahmoud, Sina Ramtin, Caroline E. Quindlen, et al.
JSES International (2025)
Closed Access

Systemic lupus erythematosus is associated with an increased risk of cervical artery dissection
Robert J. Trager, Benjamin P. Lynn, Anthony N. Baumann, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Effect of glucagon-like peptide-1 receptor agonists on vascular risk factors among adults with type 2 diabetes and established atherosclerotic cardiovascular disease
Aaron A. King, Xi Tan, Neil Dhopeshwarkar, et al.
American Journal of Preventive Cardiology (2025) Vol. 21, pp. 100922-100922
Open Access

Glucagon‐Like Peptide‐1 Receptor Agonists and Liver Outcomes in Patients With MASLD and Type 2 Diabetes
Chia‐Chih Kuo, Min‐Hsiang Chuang, Chun‐Hsien Li, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access

Prevalence of Hepatitis C Virus Among Hospitalized Patients in a Tertiary Hospital in Italy: The Basis for a National Screening Assessment Model?
Giulia Morsica, Massimo Locatelli, Gema Hernández, et al.
Microorganisms (2025) Vol. 13, Iss. 1, pp. 129-129
Open Access

The Impact of Contemporary Glucagon-like Peptide-1 Receptor Agonists on the Onset, Severity, and Conversion to Arthroplasty in Hip and Knee Osteoarthritis
Joshua R. Porto, Monish S. Lavu, Christian J. Hecht, et al.
Orthopaedic Journal of Sports Medicine (2025) Vol. 13, Iss. 1
Open Access

Metformin intake and risk of metabolic acidosis after radical cystectomy with urinary diversion: A comparative study using data from the TriNetX research network
Maximilian Pallauf, Stephan Brönimann, Michael E. Rezaee, et al.
Urologic Oncology Seminars and Original Investigations (2025)
Closed Access

Artificial intelligence methods applied to longitudinal data from electronic health records for prediction of cancer: a scoping review
Victoria Moglia, Owen Johnson, G. Elliott Cook, et al.
BMC Medical Research Methodology (2025) Vol. 25, Iss. 1
Open Access

Cardiovascular outcomes and mortality in diabetic multiple myeloma patients initiated on proteasome inhibitors according to prior use of glucagon-like peptide 1 agonists
Yu‐Cheng Chang, Chun-Yu Peng, Kuan‐Yu Chi, et al.
European Journal of Preventive Cardiology (2025)
Closed Access

Page 1 - Next Page

Scroll to top